| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/13/2006 | DE102004063494A1 Antikörper Antibody |
| 07/13/2006 | CA2614946A1 Biomarkers for melanoma |
| 07/13/2006 | CA2596706A1 Blockade of elr+cxc chemokines as a treatment for inflammatory and autoimmune disease |
| 07/13/2006 | CA2594382A1 Method of preventive treatment of allergy by oromucosal administration of an allergy vaccine |
| 07/13/2006 | CA2594276A1 Neutralizing epitope-based growth enhancing vaccine |
| 07/13/2006 | CA2594233A1 Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 ) |
| 07/13/2006 | CA2594143A1 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 07/13/2006 | CA2593212A1 Cripto binding molecules |
| 07/13/2006 | CA2593176A1 Delivery vehicles, bioactive substances and viral vaccines |
| 07/13/2006 | CA2592971A1 Method of treating brain cancer |
| 07/13/2006 | CA2592756A1 Compositions for immunizing against mycobacterium |
| 07/13/2006 | CA2592614A1 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 07/13/2006 | CA2592573A1 Multi-route administration of immune response modifier compounds |
| 07/13/2006 | CA2591138A1 Antibodies against antigen presenting cells and uses thereof |
| 07/13/2006 | CA2575248A1 Antibody vaccine conjugates and uses therefor |
| 07/13/2006 | CA2571560A1 Avipox recombinants expressing foot and mouth disease virus genes |
| 07/13/2006 | CA2564296A1 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 07/12/2006 | EP1679377A1 Feline immunodeficiency virus vaccine |
| 07/12/2006 | EP1679320A1 Derivatives of breast cancer antigen her-2 for therapeutical use |
| 07/12/2006 | EP1679080A2 Prevention and treatment of amyloidogenic disease |
| 07/12/2006 | EP1678316A2 Campylobacter polypeptides and methods of use |
| 07/12/2006 | EP1678305A2 Protozoan strains of reduced virulence and use thereof |
| 07/12/2006 | EP1678304A1 Cellular model of tauopathies for lead identification and drug discovery |
| 07/12/2006 | EP1678303A2 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 07/12/2006 | EP1678301A1 Inducible bacterial expression system utilising sspa promoter from salmonella |
| 07/12/2006 | EP1678292A2 Improved mva vaccines |
| 07/12/2006 | EP1678212A1 Hypo- and hyper-acetylated meningococcal capsular saccharides |
| 07/12/2006 | EP1678209A1 Antibodies to nik, their preparation and use |
| 07/12/2006 | EP1678206A2 Oligomeric complexe formation of recombinant multi subunit chimeric polypeptides |
| 07/12/2006 | EP1678205A1 Clq RELATED PROTEIN |
| 07/12/2006 | EP1678203A2 Multiepitope polypeptides for cancer immunotherapy |
| 07/12/2006 | EP1678199A2 Methods and compositions for mycoplasma pneumoniae exotoxins |
| 07/12/2006 | EP1678197A2 Methods and compositions for pdgf-c activation and inhibition |
| 07/12/2006 | EP1678195A2 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
| 07/12/2006 | EP1677875A1 A protein involved in ovarian cancer |
| 07/12/2006 | EP1677834A2 Defined dose therapeutic phage |
| 07/12/2006 | EP1677832A1 Lentivirus vector-based approaches for generating an immune response to hiv humans |
| 07/12/2006 | EP1677825A2 Peptide that binds to a broadly neutralizing anti-hiv antibody-structure of 4e10 fab fragment complex, uses thereof, compositions therefrom |
| 07/12/2006 | EP1677824A2 Elicitation of antibodies to self peptides in mice by immunization with dendritic cells |
| 07/12/2006 | EP1677823A1 Botulinum toxin treatments of neurological and neuropsychiatric disorders |
| 07/12/2006 | EP1677821A1 A method for increasing cd8+ cytotoxic t cell reponses and for treating multiple sclerosis |
| 07/12/2006 | EP1677820A1 Colorectal cancer antigen |
| 07/12/2006 | EP1677815A1 Selective inhibition of nf-kappab activation by peptides designed to disrupt nemo oligomerization. |
| 07/12/2006 | EP1677814A1 Filamentous haemagglutinin in the treatment and/or prophylaxis of immune-mediated disorders |
| 07/12/2006 | EP1677773A1 Combination therapy for cancer |
| 07/12/2006 | EP1677667A2 Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators |
| 07/12/2006 | EP1506225B1 Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus |
| 07/12/2006 | EP1337553B1 Nucleic acid vaccine comprising a fusion protein including an adjuvant sequence from a plant viral coat protein |
| 07/12/2006 | EP1200132B1 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 07/12/2006 | EP1150570B1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone |
| 07/12/2006 | EP1121439B1 Methods and compositions for inhibiting neoplastic cell growth |
| 07/12/2006 | EP1037645B1 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 07/12/2006 | EP0970114B1 Neoglycoproteins |
| 07/12/2006 | EP0939647B2 Neisseria meningitidis serogroup b glycoconjugates and methods of using the same |
| 07/12/2006 | CN1802388A CD20-specific antibodies and methods of employing same |
| 07/12/2006 | CN1802176A Therapy of autoimmune disease in a patient with an inadequate response to TNF-ALPHA inhibitor |
| 07/12/2006 | CN1802175A Cells used as carriers for bacteria |
| 07/12/2006 | CN1802174A Tumor antigen BFA5 for prevention and / or treatment of cancer |
| 07/12/2006 | CN1802173A Packaged virus-like particles |
| 07/12/2006 | CN1802172A Therapeutic composition for autoimmune conditions |
| 07/12/2006 | CN1802170A Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 07/12/2006 | CN1800406A Method for expressing medical protein using trangene plant |
| 07/12/2006 | CN1800375A Recombinant adenovirus of porcine reproductive and respirator syndrome virus and porcine Circovirus, and vaccine |
| 07/12/2006 | CN1800374A Recombinant gene engineered strain of aujeszkys disease-porcine reproductive and respirator syndrome virus and its uses |
| 07/12/2006 | CN1800373A Hybridoma cell strain and its produced human VEGFR-3 resistant monoclonal antibody |
| 07/12/2006 | CN1800359A Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 07/12/2006 | CN1800210A Compounds for treatment of infectious and immune system disorders and methods for their use |
| 07/12/2006 | CN1799628A Mixed heat shock protein/peptide sarcoma vaccine and its preparation method |
| 07/12/2006 | CN1799378A Human colostrum-simulated biological milk powder |
| 07/12/2006 | CN1263861C Compact epstein-barr virus peplicons |
| 07/12/2006 | CN1263854C Neisserial antigens |
| 07/12/2006 | CN1263848C Artificially recombinant H9N2 hypotype influenza virus and its uses |
| 07/12/2006 | CN1263730C Esters of L-carnitine or alkanoyl L-carnitines used as cation lipid for intracellular release pharmacological activity compound |
| 07/12/2006 | CN1263511C Live recombined vaccines injected with adjuvant |
| 07/12/2006 | CN1263510C Polysaccharide protein conjugate or oligosaccharide-protein conjugate, preparation method and application thereof |
| 07/12/2006 | CN1263509C Novel compositions |
| 07/12/2006 | CN1263508C Stabilizers for live vaccines |
| 07/12/2006 | CN1263507C APRIL receptor (BCMA) and uses thereof |
| 07/12/2006 | CN1263465C Copper agonist that binds on the copper binding site of APP and/or exerts an inhibiting effect on the release of anyloid A beta peptide |
| 07/12/2006 | CA2489780A1 Methods for preventing or treating a condition or a disease associated with angiogenesis |
| 07/11/2006 | US7074909 Prevent, therapy of disease; isolated nucleic acid which codes antibody; binding to human antigen |
| 07/11/2006 | US7074904 MHC molecule that contains a peptide-binding groove, and a presenting peptide covalently linked to the MHC molecule, the fusion complex being capable of modulating the activity of a T cell. |
| 07/11/2006 | US7074900 Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin |
| 07/11/2006 | US7074898 Polypeptide for use as an antiproliferative agent in the treatment of cell proliferative disorders |
| 07/11/2006 | US7074896 Gene expression of nucleic acid in prokaryotic cells; homogeneity, purity; immobilization; separation of antibodies by chromatography |
| 07/11/2006 | US7074894 Antigen composition against mycoplasma |
| 07/11/2006 | US7074771 Gene encoding MNR2 and uses thereof |
| 07/11/2006 | US7074770 Administering to a mammal a vector or nucleotide sequence which code an antigenic peptide; together with Schiff base |
| 07/11/2006 | US7074768 Modified protein kinase A-specific oligonucleotides and methods of their use |
| 07/11/2006 | US7074613 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 07/11/2006 | US7074580 obtaining a sequence-defined molecular weight markers that provide an accurate and robust calibration set for determinations of molecular weight of production batches; subjecting the molecular weight markers to column chromatography to establish a relationship between retention time and molecular weight |
| 07/11/2006 | US7074574 Method of detecting growth differentiation factor-7 (GDF-7) using GDF-7 antibodies |
| 07/11/2006 | US7074559 Comprises nucleotide sequences coding mycobacterium paratuberculosis polypeptides for immunization and prevention of mycobacterial animal infections |
| 07/11/2006 | US7074416 Antigen of hybrid M protein and carrier for group A streptococcal vaccine |
| 07/11/2006 | US7074415 Polypeptide antigens of streptococcus pneumoniae pathogen which may be useful for prophylaxis, diagnostic or treatment of streptococcal infection |
| 07/11/2006 | US7074414 Cold-adapted equine influenza viruses |
| 07/11/2006 | US7074413 Using reverse genetics to combine the antigenic determinants that render the rabies virus non-pathogenic with the determinants that are responsible for the elicitation of an effective anti-rabies immune response |
| 07/11/2006 | US7074412 For therapy of orthopaedic and dental, including periodontal, diseases |
| 07/11/2006 | US7074411 α-β C4BP-type recombinant heteromultimeric proteins |
| 07/11/2006 | US7074410 Modified HCV peptide vaccines |